Literature DB >> 1629705

In vitro reconstitution of active influenza virus ribonucleoprotein complexes using viral proteins purified from infected cells.

J Martín1, C Albo, J Ortín, J A Melero, A Portela.   

Abstract

A procedure to obtain RNA-free preparations containing the nucleoprotein (NP) and polymerase (P) proteins from influenza virus-infected cell extracts has been developed. The influenza virus P proteins present in these preparations copied small synthetic RNA molecules derived from plasmid sequences. In addition, RNA molecules encapsidated with the NP and P proteins were amplified and packaged into virus particles when transfected into influenza virus-infected cells. Thus, the preparations of NP and P proteins display features similar to those isolated from purified influenza virions, and represent an alternative for the preparation of active influenza virus P protein.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1629705     DOI: 10.1099/0022-1317-73-7-1855

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  12 in total

1.  The RNA polymerase of influenza virus, bound to the 5' end of virion RNA, acts in cis to polyadenylate mRNA.

Authors:  L L Poon; D C Pritlove; J Sharps; G G Brownlee
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

2.  Attenuation of influenza A virus mRNA levels by promoter mutations.

Authors:  E Fodor; P Palese; G G Brownlee; A García-Sastre
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

3.  A hairpin loop at the 5' end of influenza A virus virion RNA is required for synthesis of poly(A)+ mRNA in vitro.

Authors:  D C Pritlove; L L Poon; L J Devenish; M B Leahy; G G Brownlee
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

4.  Polyadenylation of influenza virus mRNA transcribed in vitro from model virion RNA templates: requirement for 5' conserved sequences.

Authors:  D C Pritlove; L L Poon; E Fodor; J Sharps; G G Brownlee
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

5.  A 48-amino-acid region of influenza A virus PB1 protein is sufficient for complex formation with PA.

Authors:  D R Pérez; R O Donis
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

6.  Influenza virus PB1 protein is the minimal and essential subunit of RNA polymerase.

Authors:  M Kobayashi; T Toyoda; A Ishihama
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

7.  Recombinant influenza virus polymerase: requirement of both 5' and 3' viral ends for endonuclease activity.

Authors:  M Hagen; T D Chung; J A Butcher; M Krystal
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

8.  A plasmid-based reverse genetics system for influenza A virus.

Authors:  S Pleschka; R Jaskunas; O G Engelhardt; T Zürcher; P Palese; A García-Sastre
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

9.  Serine 3 is critical for phosphorylation at the N-terminal end of the nucleoprotein of influenza virus A/Victoria/3/75.

Authors:  M Arrese; A Portela
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

10.  Mutational analysis of influenza A virus nucleoprotein: identification of mutations that affect RNA replication.

Authors:  I Mena; E Jambrina; C Albo; B Perales; J Ortín; M Arrese; D Vallejo; A Portela
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.